ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Janssen Reports Top-Line Phase 3 Results for TREMFYA? americanpharmaceuticalreview
June 20, 2019The Janssen Pharmaceutical Companies of Johnson & Johnson announced top-line results from the Phase 3 DISCOVER 1 and 2 studies, which evaluated the efficacy and safety of guselkumab compared to placebo in adult patients with active moderate to severe psor
Pharma Sources Insight January 2025
